COMMUNIQUÉS West-GlobeNewswire

MDxHealth (R): SelectMDx Outperforms Prostate Health Index (phi) Blood Test for Detecting High-Grade Prostate Cancer

24/01/2019 - 07:01

NEWS RELEASE REGULATED INFORMATION Data to be presented at the 29th Annual IPCU meeting Beaver Creek, Co, January 24-27, 2019 IRVINE, CA, and HERSTAL, BELGIUM - January 24, 2019 - MDxHealth SA (Euronext: MDXH.BR) today [...]

MDxHealth (R) : Le test SelectMDx est plus performant que le test sanguin PHi dans la détection du cancer de la prostate de haut grade

24/01/2019 - 07:01

COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉES Les données seront présentées lors de la 29 e conférence annuelle IPCU qui se tiendra à Beaver Creek, Colorado, du 24 au 27 janvier 2019. IRVINE, CALIFORNIE, et HERSTAL, [...]

Telix Group Expands Prostate Imaging Capability through ININ Technology Partnership

24/01/2019 - 01:15

MELBOURNE, Australia and LIEGE, Belgium, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Advanced Nuclear Medicine Ingredients SA (“ANMI”), a wholly-owned subsidiary of Telix Pharmaceuticals Limited (ASX:TLX, “Telix”) today announced [...]

Ohr Pharmaceutical Announces Reverse Stock Split to be Effective February 4, 2019

23/01/2019 - 22:30

Previously announced merger with NeuBase Therapeutics remains on track NEW YORK, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (“Ohr” or the “Company”) (Nasdaq: OHRP) announced today that its board of [...]

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares

23/01/2019 - 22:23

CAMBRIDGE, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a genetic medicines company focused on delivering transformational therapies for patients with serious, genetically-defined [...]

Conformis to Host Fourth Quarter and Fiscal Year 2018 Financial Results Webcast on February 6, 2019

23/01/2019 - 22:10

BILLERICA, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast on Wednesday, February 6, 2019, at 4:30 p.m. Eastern Time to discuss its financial results [...]

HTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program

23/01/2019 - 22:05

TUCSON, Ariz., Jan. 23, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has appointed Dr. Joseph [...]

Bio-Path Holdings, Inc. Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market

23/01/2019 - 22:01

HOUSTON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (Nasdaq: BPTH) (Bio-Path), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio [...]

Revive Provides an Update on the Non-Brokered Private Placement

23/01/2019 - 22:00

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Jan. 23, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics [...]

62 Genesis HealthCare Facilities Identified by U.S. News & World Report as Best Nursing Homes for 2018-2019

23/01/2019 - 21:37

KENNETT SQUARE, Pa., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Genesis HealthCare , one of the largest post-acute care providers in the United States, today announced that 62 of its skilled nursing facilities were identified as [...]

Biocartis Group NV: BIOCARTIS SUCCESSFULLY RAISES EUR 55.50 MILLION

23/01/2019 - 21:31

PRESS RELEASE: REGULATED INFORMATION - INSIDE INFORMATION 23 January 2019, 21:30 CET BIOCARTIS SUCCESSFULLY RAISES EUR 55.50 MILLION IN AN EQUITY PLACEMENT Mechelen, Belgium , 23 January 2019 - Biocartis Group NV (the " [...]

Microbot Medical Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market

23/01/2019 - 21:26

HINGHAM, Mass., Jan. 23, 2019 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]

CORRECTING and REPLACING – Aurora Spine Announces New Patent for Its Minimally Invasive Spinal Implants Allowed by the United States Patent Office

23/01/2019 - 20:39

CARLSBAD, Calif., Jan. 23, 2019 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Aurora Spine Corporation (TSXV: ASG) please note that “Expendable Interspinous Device" has been changed to [...]

The Biggest CBD-Infused Beverage Trends for 2019 and the Stocks Involved

23/01/2019 - 20:34

VANCOUVER, British Columbia, Jan. 23, 2019 (GLOBE NEWSWIRE) -- With the success of the 2018 Farm Bill in the rearview, investors are already setting their sights on what’s next: CBD-infused beverages. CBD-infused coffee [...]

Easton Announces Completion of Financial Statements With $200,000 in Sales in Quarter Ending Sept. 30th, 2018 and Revenue for Quarter Ending December 31, 2018

23/01/2019 - 20:29

TORONTO, ON, Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces completion of its financial statements with $200,000 in sales in its quarter ending September 30 th [...]

BLVD Centers Announces Support for Medical Cannabis Research

23/01/2019 - 18:50

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- BLVD Centers [...]

BLVD Centers Announces Support for Medicial Cannabis Research

23/01/2019 - 18:11

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, Jan. 23, 2019 (GLOBE NEWSWIRE) -- BLVD Centers [...]

Changes to Zealand Pharma’s Executive Management

23/01/2019 - 17:40

Company announcement – No. 1/2019 Changes to Zealand Pharma’s Executive Management Copenhagen, Denmark, January 23, 2019 – Zealand Pharma A/S today announced changes to its Executive Management. Following the [...]

Biocartis Group NV: BIOCARTIS UPSIZES ITS EQUITY PLACEMENT DUE TO SIGNIFICANT DEMAND

23/01/2019 - 17:16

PRESS RELEASE : REGULATED INFORMATION - INSIDE INFORMATION 23 January 2019, 17:15 CET BIOCARTIS UPSIZES ITS EQUITY PLACEMENT DUE TO SIGNIFICANT DEMAND Mechelen, Belgium , 23 January 2019 - Biocartis Group NV (the " [...]